Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07819539) titled 'Anthocyanin-Rich Berry Supplementation in Patients With Colorectal Cancer' on Sept. 9.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Jagiellonian University
Condition:
Colorectal Cancer
Intervention:
Dietary Supplement: Anthocyanin-Rich Freeze-Dried Berry Supplement
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: May 24, 2023
Target Sample Size: 70
Countries of Recruitment:
Poland
To know more, visit https://clinicaltrials.gov/study/NCT078195...